Industry News
As part of an industry that relies on innovation and challenges to grow and thrive, ViVitro is pleased to offer you the latest industry news through our website and newsletter. Should you wish to contribute a news item to be featured in our newsletter or website, please don't hesitate to contact us!
Jarvik Heart Announces FDA Conditional Approval of Trial Using Device for Destination Therapy
ViVitro Labs Releases Simulated Use Tester/ Endovascular Procedure Simulator for Stents, Stent Grafts, and Transcatheter Heart Valves
February 9, 2012 (Victoria, B.C.): ViVitro Labs Inc., the leader in prosthetic heart valve testing and a global provider of cardiovascular device testing equipment and ISO 17025 accredited laboratory services, has released its EV Simulator. Designed for cost effective simulated use testing and endovascular simulation training, this system utilizes the Pulse Duplicator and SuperPump AR technology for which the company is well-known. The ViVitro EV Simulator provides a unique compact design that minimizes connecting hoses and controls flow and pressures while using the ViVitro Superpump to emulate the physiological function of various vascular models. Read complete press release
VNews, Winter 2012 – Cardiovascular Device Testing Newsletter
Why lab certification/accreditation matters; Are you a THV native or a foreigner in a strange land, and the value of using raw data - all in this issue of ViVitro Labs’ VNews – Read the newsletter now!
Please type your email address into the form below and click the "subscribe" button, to be added to our VNews mailing list.
